Navigation Links
Nanofibrillar cellulose film to ease performing medical tests
Date:10/25/2012

Researchers at Aalto University in Finland have succeeded in developing a durable and affordable nanofibrillar cellulose film platform to support medical testing. New environmentally friendly, reliable nanofibrillar cellulose (NFC) platforms are more diverse than plastic films. New film can be made, for instance, hydrophobic, hydrophilic and the electric charge can be changed. This will enhance the possibility of conducting thousands of different medical tests at home or in physicians' receptions instead of waiting for results from laboratories.

A platform is coated with the new film in the factory. The film is injected with substances that will react to the tested substance. At the place of testing, blood, water or another test material will be applied on to the film. The antibody injected onto the film will absorb the sample, depending on whether it contains substances causing allergic reactions, or bacteria, for example. Then the test result is visualised with the help of colour changing chemistry, for example.

Thanks to the new film, various tests can be conducted faster without compromising reliability. It will now be easier to detect microbes that cause illnesses in the physician's reception, or to monitor allergens at home. In addition to medical diagnostics, the film can be utilised to study water purity, for example, says doctoral candidate Hannes Orelma at Aalto University.

Previous attempts to produce a nanofibrillar cellulose platform have failed when the porous plate absorbed part of the sample. Now researchers have developed a method of producing a water proof nanofibrillar cellulose gel that will not absorb samples. They have also made great efforts to ensure sufficient film durability.


'/>"/>
Contact: Hannes Orelma
hannes.orelma@aalto.fi
358-503-441-074
Aalto University
Source:Eurekalert  

Page: 1

Related biology technology :

1. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
2. Germany Prioritizes Medical Biotechnology with New Initiatives
3. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
4. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
5. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems Announces Successful Production of Hemp Harvesting for High Value CBD Oil
6. AFCell Medical Reports Results from the Retrospective Study of a Novel Allograft Membrane to Prevent Post-Operative Adhesions in the Repair of Peroneal and Posterior Tibial Tendons
7. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
8. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
9. Global Medical Laboratories Industry
10. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
11. Medical Marijuana Inc. Product, CanChew Bio-Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nanofibrillar cellulose film to ease performing medical tests
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
(Date:3/22/2017)... TORONTO , March 22, 2017 /PRNewswire/ - ... Therapeutics (the "Company" or "Propellon"), a start-up created ... WDR5-targeted anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive ... lead program. The seed funding enables Propellon to ... position the Company for financing and/or entering a ...
(Date:3/22/2017)... ... 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL will be the ... “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” As the Bahamas’ ... and Therapy Act, Okyanos maintains a mission to help “no-option” patients and those ...
Breaking Biology Technology:
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant kiosk ... At PTE 2017 ... Materna will present its complete end-to-end passenger journey, from ... benefit for passengers. To accelerate the whole passenger handling process, ... to take passengers through the complete integrated process with a ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
Breaking Biology News(10 mins):